Company Filing History:
Years Active: 2016
Title: Celebrating the Innovations of Kathleen Simons in Biochemical Advances
Introduction: Kathleen Simons is a groundbreaking inventor based in Basel, Switzerland. With a strong focus on the biochemical applications of proteins, she has made significant contributions to the field of nutrition and health, exemplified by her patent related to tryptophan-rich protein hydrolysates.
Latest Patents: One of Kathleen’s most notable patents is for a method aimed at enhancing feelings of energy, cognitive functions, quality of sleep, and overall well-being in healthy adults. Her invention focuses on a specific dosage form comprising a low dose of tryptophan-containing di- and/or tri-peptide mixture. This composition is derived from egg lysozyme hydrolysate and features a tryptophan-to-large neutral amino acids (Trp/LNAA) ratio greater than 0.15, providing a dosage of up to 100 mg of tryptophan per dose. This methodology allows for acute administration or multiple daily doses over extended periods, demonstrating her innovative approach to improving health outcomes.
Career Highlights: Kathleen is associated with DSM IP Assets B.V., where she applies her expertise to further her research and development efforts. Her work in this company highlights her commitment to innovation within the field of nutritional science and health.
Collaborations: Kathleen collaborates with esteemed colleagues like Leigh Gibson and Regina Goralczyk. Together, they work on advancing research initiatives that combine their expertise to explore the benefits of dietary interventions on mental and physical well-being.
Conclusion: Kathleen Simons stands out as a prominent inventor, whose innovative approaches have the potential to revolutionize how we understand nutrition and its impacts on health. With her commitment to research and collaboration, she continues to pave the way for new discoveries in the field of biochemical applications.